Literature DB >> 8584047

Evidence against a role of nitric oxide in the indirect negative inotropic-effect of M-cholinoceptor stimulation in human ventricular myocardium.

H Kilter1, O Lenz, K La Rosée, M Flesch, R H Schwinger, M Mädge, F Kuhn-Regnier, M Böhm.   

Abstract

Nitric oxide (NO) has been reported to mediate several effects in response to muscarinic cholinergic stimulation in cardiovascular tissues. Recently, an attenuation of guinea pig cardiac myocyte contraction by NO has been described. The aim of the present study was to determine whether the indirect negative inotropic effect of M-cholinoceptor stimulation in human myocardium is in part due to an effect of endogenous NO. Therefore, the effect of carbachol was studied under control conditions and during inhibition of NO-synthase by pretreatment with NG-monomethyl-L-arginine (NMMA). Functional experiments were performed in isolated, electrically driven (1 Hz, 37 degrees C) left ventricular papillary muscle strips of human myocardium. Since cytokines have been reported to be increased in the serum of patients with heart failure and could induce NO-synthase activity in failing myocardium, we compared samples from nonfailing and terminally failing (classified as NYHA IV) hearts. The indirect negative inotropic effect of carbachol (10 mumol/l) was studied in the presence of the beta-adrenoceptor agonist isoprenaline (0.03 mumol/l). After stimulation with isoprenaline, carbachol significantly (P < 0.05) reduced force of contraction. This effect was diminished in failing myocardium compared to nonfailing, probably due to the diminished inotropic response most likely due to the lower cAMP levels in response to beta-adrenoceptor stimulation in the former condition. Pretreatment with NMMA (100 mumol/l) altered the antiadrenergic effect of carbachol neither in nonfailing nor in failing preparations. Furthermore, inhibition of guanylyl cyclase, the target enzyme of NO, by preincubation with methylene blue (10 mumol/l) for 30 min had no effect on the carbachol-induced decrease in force of contraction.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8584047     DOI: 10.1007/bf00168562

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  40 in total

1.  Pertussis toxin inhibits negative inotropic and negative chronotropic muscarinic cholinergic effects on the heart.

Authors:  S Tucek; V Dolezal; J Folbergrová; S Hynie; F Kolár; B Ostádal
Journal:  Pflugers Arch       Date:  1987-02       Impact factor: 3.657

2.  Cyclic GMP-dependent protein kinase phosphorylates phospholamban in isolated sarcoplasmic reticulum from cardiac and smooth muscle.

Authors:  L Raeymaekers; F Hofmann; R Casteels
Journal:  Biochem J       Date:  1988-05-15       Impact factor: 3.857

3.  Opposite effects of cyclic GMP and cyclic AMP on Ca2+ current in single heart cells.

Authors:  H C Hartzell; R Fischmeister
Journal:  Nature       Date:  1986 Sep 18-24       Impact factor: 49.962

4.  Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium.

Authors:  M Böhm; D Beuckelmann; L Brown; G Feiler; B Lorenz; M Näbauer; B Kemkes; E Erdmann
Journal:  Eur Heart J       Date:  1988-08       Impact factor: 29.983

Review 5.  Role of endothelium in responses of vascular smooth muscle.

Authors:  R F Furchgott
Journal:  Circ Res       Date:  1983-11       Impact factor: 17.367

6.  Oppositional effects of acetylcholine and isoproterenol on isometric tension and cyclic nucleotide concentrations in rabbit atria.

Authors:  W J George; L J Ignarro; R J Paddock; L White; P J Kadowitz
Journal:  J Cyclic Nucleotide Res       Date:  1975

7.  Negative inotropic effects of cytokines on the heart mediated by nitric oxide.

Authors:  M S Finkel; C V Oddis; T D Jacob; S C Watkins; B G Hattler; R L Simmons
Journal:  Science       Date:  1992-07-17       Impact factor: 47.728

8.  Modification by islet-activating protein of receptor-mediated regulation of cyclic AMP accumulation in isolated rat heart cells.

Authors:  O Hazeki; M Ui
Journal:  J Biol Chem       Date:  1981-03-25       Impact factor: 5.157

9.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts.

Authors:  M R Bristow; R Ginsburg; W Minobe; R S Cubicciotti; W S Sageman; K Lurie; M E Billingham; D C Harrison; E B Stinson
Journal:  N Engl J Med       Date:  1982-07-22       Impact factor: 91.245

10.  Nitric oxide synthase activities in human myocardium.

Authors:  A J de Belder; M W Radomski; H J Why; P J Richardson; C A Bucknall; E Salas; J F Martin; S Moncada
Journal:  Lancet       Date:  1993-01-09       Impact factor: 79.321

View more
  3 in total

1.  Inotropic response to beta-adrenergic receptor stimulation and anti-adrenergic effect of ACh in endothelial NO synthase-deficient mouse hearts.

Authors:  A Gödecke; T Heinicke; A Kamkin; I Kiseleva; R H Strasser; U K Decking; T Stumpe; G Isenberg; J Schrader
Journal:  J Physiol       Date:  2001-04-01       Impact factor: 5.182

2.  Role of the NO-cGMP pathway in the muscarinic regulation of the L-type Ca2+ current in human atrial myocytes.

Authors:  G Vandecasteele; T Eschenhagen; R Fischmeister
Journal:  J Physiol       Date:  1998-02-01       Impact factor: 5.182

Review 3.  Nitric oxide control of cardiac function: is neuronal nitric oxide synthase a key component?

Authors:  Claire E Sears; Euan A Ashley; Barbara Casadei
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-06-29       Impact factor: 6.237

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.